Index
S&P 500
Market Cap
11.47B
Enterprise Value
13.86B
Income
570.30M
Sales
4.24B
Book/sh
43.81
Cash/sh
0.81
Employees
15000
IPO
Jan 21, 1983
P/E
20.58
Forward P/E
12.88
PEG
1.78
P/S
2.71
P/B
1.38
P/C
74.02
P/FCF
16.91
EV/EBITDA
11.55
EV/Sales
3.27
Quick Ratio
0.73
Current Ratio
1.22
Debt/Eq
0.31
LT Debt/Eq
0.23
Option/Short
Yes / Yes
EPS (ttm)
2.93
EPS next Y
4.68
EPS next Q
1.07
EPS this Y
9.96%
EPS next Y
3.32%
EPS next 5Y
7.25%
EPS past 3/5Y
-1.15% 9.30%
Sales past 3/5Y
7.35% 10.98%
EPS Y/Y TTM
43.89%
Sales Y/Y TTM
4.73%
EPS Q/Q
355.30%
Sales Q/Q
0.56%
Insider Own
0.64%
Insider Trans
2.94%
Inst Own
111.80%
Inst Trans
1.22%
ROA
4.55%
ROE
6.84%
ROIC
5.57%
Gross Margin
61.39%
Oper. Margin
19.26%
Profit Margin
13.46%
SMA20
4.22%
SMA50
-0.07%
SMA200
-12.48%
Trades
Shs Outstand
190.10M
Shs Float
188.94M
52W High
89.83 -32.87%
52W Low
51.01 18.21%
Volatility
2.23% 2.40%
ATR (14)
1.46
RSI (14)
55.98
Beta
0.84
Rel Volume
0.00
Avg Volume
3.36M
Volume
360
Perf Week
-1.49%
Perf Month
5.03%
Perf Quarter
-18.77%
Perf Half Y
-3.30%
Perf YTD
-26.43%
Perf Year
-13.99%
Perf 3Y
-22.08%
Perf 5Y
-42.15%
Perf 10Y
37.55%
Prev Close
60.34
Price
60.30
Change %
-0.07%
Analysts 15 incl. previous ratings
Rating Distribution 4 Buy · 10 Hold · 1 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Oct 07, 2026 Initiated B Barclays
Equal Weight $60 -0.5% Sep 10, 2026 Downgrade W William Blair
Outperform → Mkt Perform Sep 10, 2026 Downgrade R Robert W. Baird
Outperform → Neutral $61 +1.2% Sep 10, 2026 Downgrade P Piper Sandler
Overweight → Neutral $59 -2.2% Sep 10, 2026 Downgrade B BofA Securities
Buy → Neutral $65 +7.8% Jul 28, 2026 Initiated U UBS
Neutral $75 +24.4% Jun 05, 2026 Reiterated N Needham
Buy $101 → $86 +42.6% Mar 04, 2026 Downgrade R Rothschild & Co Redburn
Buy → Neutral $85 +41.0% Feb 03, 2026 Reiterated N Needham
Buy $100 → $99 +64.2% Nov 13, 2025 Downgrade W Wells Fargo
Overweight → Equal Weight $72 +19.4% Oct 13, 2025 Initiated B Barclays
Overweight $85 +41.0% Oct 01, 2025 Initiated G Goldman
Sell $64 +6.1% Aug 28, 2025 Downgrade C Citigroup
Buy → Neutral $72 +19.4% Jul 22, 2025 Upgrade B BNP Paribas Exane
Neutral → Outperform $92 +52.6% Jun 17, 2025 Upgrade N Needham
Hold → Buy $94 +55.9% May 30, 2025 Downgrade J JP Morgan
Overweight → Neutral $76 +26.0% Aug 29, 2024 Reiterated P Piper Sandler
Overweight $115 → $120 +99.0% Jul 16, 2024 Upgrade J Jefferies
Hold → Buy $107 → $115 +90.7% Mar 19, 2024 Upgrade R Redburn Atlantic
Neutral → Buy $125 +107.3% Mar 13, 2024 Upgrade J JP Morgan
Neutral → Overweight $100 → $120 +99.0%
Show Previous Ratings
Oct-29-26 11:58AM
Oct-27-26 04:28PM
Oct-07-26 10:00AM
Oct-01-26 05:03PM
Sep-23-26 04:15PM
01:49PM
Loading…
01:49PM
10:00AM
Sep-21-26 07:47AM
Sep-18-26 08:50AM
07:37AM
07:00AM
Sep-14-26 02:45PM
12:46PM
Sep-10-26 02:24PM
10:47AM
10:02AM
Loading…
10:02AM
(Investor's Business Daily)
09:52AM
07:00AM
06:30AM
06:27AM
05:33AM
05:00AM
Sep-09-26 05:00PM
04:31PM
04:17PM
04:15PM
05:01AM
03:31AM
Jul-30-26 04:15PM
Jul-28-26 09:34AM
04:15PM
Loading…
Jun-30-26 04:15PM
Jun-05-26 12:00PM
01:00AM
Jun-04-26 04:15PM
May-29-26 08:05AM
May-13-26 05:52PM
May-04-26 04:15PM
Apr-30-26 04:15PM
Apr-09-26 08:05AM
Mar-17-26 08:19AM
Mar-13-26 11:55AM
Mar-09-26 05:24PM
09:40AM
09:15AM
Mar-07-26 08:15AM
Mar-06-26 04:42PM
12:45PM
11:18AM
10:45AM
10:05AM
09:45AM
09:20AM
09:14AM
06:29AM
03:05AM
12:01AM
Mar-05-26 08:18PM
06:00PM
05:30PM
04:33PM
04:15PM
Mar-04-26 09:39AM
07:59AM
07:54AM
Mar-03-26 05:15PM
Mar-02-26 09:36AM
09:15AM
Feb-26-26 10:00AM
Feb-25-26 08:28AM
Feb-24-26 07:30PM
12:31PM
08:31AM
Feb-23-26 08:46AM
08:45AM
Feb-18-26 07:42AM
Feb-17-26 01:44PM
09:27AM
Feb-13-26 11:40AM
Feb-11-26 01:34PM
Feb-10-26 09:23AM
Feb-05-26 04:15PM
Feb-04-26 05:20PM
Feb-03-26 01:17PM
12:10PM
08:05AM
Feb-02-26 11:57AM
Jan-29-26 11:38PM
12:17PM
Jan-28-26 11:40AM
Jan-27-26 12:19PM
09:45AM
Jan-26-26 09:40AM
Jan-23-26 01:50PM
07:57AM
Jan-22-26 11:08AM
10:43AM
Jan-21-26 11:43AM
Jan-14-26 12:50PM
Jan-13-26 11:16AM
Jan-12-26 11:40AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Kurzius Lawrence Erik Director Sep 16 '26 Buy 54.93 10,000 549,320 31,099 Sep 17 04:22 PM Rosebrough Walter M Jr Director Sep 11 '26 Buy 54.11 7,000 378,770 17,000 Sep 15 04:56 PM Rosebrough Walter M Jr Director Sep 14 '26 Buy 54.29 3,000 162,870 20,000 Sep 15 04:56 PM Kurzius Lawrence Erik Director Sep 14 '26 Buy 53.91 10,000 539,150 21,099 Sep 15 04:53 PM Keel Paul A Director Sep 11 '26 Buy 53.18 4,701 250,000 4,701 Sep 15 04:46 PM Rosebrough Walter M Jr Director Apr 01 '26 Option Exercise 0.00 832 0 832 Apr 21 05:45 PM WEISS ROBERT S Director Apr 01 '26 Option Exercise 0.00 3,654 0 292,599 Apr 06 05:16 PM Rivas Maria Director Apr 01 '26 Option Exercise 0.00 3,322 0 3,322 Apr 06 05:16 PM Jay Colleen Director Apr 01 '26 Option Exercise 0.00 3,322 0 39,907 Apr 06 05:16 PM Carbone Barbara Director Apr 01 '26 Option Exercise 0.00 3,050 0 3,050 Apr 06 05:15 PM MADDEN TERESA S Director Apr 01 '26 Option Exercise 0.00 3,322 0 15,679 Apr 06 05:15 PM Lucchese Cynthia L Director Apr 01 '26 Option Exercise 0.00 3,322 0 12,767 Apr 06 05:14 PM Kurzius Lawrence Erik Director Apr 01 '26 Option Exercise 0.00 3,322 0 11,099 Apr 06 05:14 PM Jay Colleen Director Jan 12 '26 Option Exercise 39.40 7,064 278,322 36,585 Jan 14 04:05 PM White Albert G III President & CEO Jan 08 '26 Option Exercise 0.00 18,340 0 254,491 Jan 12 04:24 PM Warner Gerard H III President, CooperVision, Inc. Jan 08 '26 Option Exercise 0.00 11,518 0 29,837 Jan 12 04:24 PM Sheffield Holly R President, CSI Jan 08 '26 Option Exercise 0.00 8,050 0 47,102 Jan 12 04:23 PM McBride Daniel G EVP & Chief Operating Officer Jan 08 '26 Option Exercise 0.00 12,887 0 76,007 Jan 12 04:23 PM Andrews Brian G EVP, CFO & Treasurer Jan 08 '26 Option Exercise 0.00 3,528 0 10,430 Jan 12 04:22 PM Lucchese Cynthia L Director Dec 22 '25 Buy 84.06 1,784 149,963 9,445 Dec 23 04:08 PM Rivas Maria Director Dec 18 '25 Buy 82.13 1,000 82,130 11,141 Dec 19 04:18 PM Kurzius Lawrence Erik Director Dec 17 '25 Buy 82.50 2,000 165,000 7,777 Dec 17 05:06 PM Sheffield Holly R President, CSI Dec 16 '25 Buy 80.75 1,230 99,322 39,052 Dec 16 06:36 PM White Albert G III President & CEO Dec 16 '25 Buy 80.80 10,000 808,000 236,151 Dec 16 06:36 PM
The Cooper Cos, Inc. operates as a medical device company. It operates through the CooperVision and CooperSurgical segments. The CooperVision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The CooperSurgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.
President Mr. Albert G. White III
Executive VP Mr. Brian G. Andrews
Executive VP Mr. Daniel G. McBride Esq.
President of CooperSurgical Ms. Holly R. Sheffield
President of CooperVision Mr. Gerard H. Warner III